Cancer Biology & Medicine

Several invited reviews were included in the 3rd issue, which focused on Warburg effect and related proton homeostasis in proliferating cells (Prof. Binghui Li, et al.); tissue specificity of DNA damage response and tumorigenesis (Prof Mo Li, et al.); targeted intervention in malignancy (Prof. Yukun Cui, et al.); and nanotechnology in cancer immunotherapy (Prof. Ning Gu, et al.) as well. Except for the above reviews on basic medicine, Prof. Masatoshi Makuuchi contributed a review on precision surgery for primary liver cancer. As a matter of fact, other reviews also brought some novel academic viewpoints on cancer translational researches.

Although all the original articles are worthy of reading, we still recommend two papers on cancer epidemiology, namely, “Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients” by Prof. Chengping Hu et al. and “Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China” by Wanqing Chen et al. Whereas, other researches displayed advances in aspects of molecular mechanisms and application in cancer diagnosis and treatment, which includes many types of malignancies, such as melanoma, gastric

cancer , lymphoma, colorectal cancer , non-small cell lung cancer, soft tissue sarcoma, breast cancer, papillary thyroid microcarcinoma, glioblastoma, hepatocellular carcinoma, and so on.

We hope the content of this issue will greatly benefit your research and clinical practice. Thank you for your attention and welcome to submit your work to Cancer Biology & Medicine.